$26.99▲0.00 (0.00%)Earnings · Nov 26
Extended:$26.99+0.00 (+0.00%)· 9:50 PM ET
Fisher & Paykel Healthcare Corporation Limited (FSPKF)
R&D to Revenue
10.07%
Fiscal year · Period ending:

FSPKF R&D to Revenue
Latest reported10.07%period ending
Latest reported10.07%period ending
FSPKF FY R&D/Revenue (3.72% → 10.07%)
Latest values, visible window
High-resolution chart · PNG
What is r&d to revenue?
R&D spending as percentage of revenue.
FSPKF r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 10.0684% | |
| 11.2271% | |
| 11.2735% | |
| 10.9719% | |
| 9.3765% | |
| 7.0167% | |
| 9.3058% | |
| 9.3648% | |
| 9.8186% | |
| 9.8908% | |
| 8.954% | |
| 10.0909% | |
| 9.5227% | |
| 9.0133% | |
| 8.9963% | |
| 8.3983% | |
| 7.4295% | |
| 5.8309% | |
| 6.9634% | |
| 6.026% | |
| 5.9914% | |
| 6.7325% | |
| 0% | |
| 0% | |
| 5.7973% | |
| 3.7237% |
Explore More
FSPKF Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance